| Home | E-Submission | Sitemap | Contact Us |  
Algae > Volume 37(3); 2022 > Article
Lee, Nagahawatta, Liyanage, Jayawardhana, Yang, Je, Kang, Kim, and Jeon: Structural characterization and anti-inflammatory activity of fucoidan isolated from Ecklonia maxima stipe


Enzyme-assisted hydrolysis is frequently used as a cost-effective and efficient method to obtain functional ingredients from bioresources. This study involved the enzyme-assisted hydrolyzation and purification of fucoidan from Ecklonia maxima stipe and the investigation of its anti-inflammatory activity in lipopolysaccharide (LPS)-induced RAW 264.7 cells. Fucoidans of Viscozyme-assisted hydrolysate from E. maxima (EMSFs) harvested in Jeju, Korea. Structural and chemical characterizations were performed using fourier transform infrared spectroscopy, scanning electron microscope, and monosaccharide analysis. Among fucoidans, EMSF6 was rich in fucose and sulfate and had a similar structural character to commercial fucoidan. EMSF6 showed a strong inhibitory effect on nitric oxide generation in LPS-induced RAW 264.7 cells and significantly decreased the production of LPS-induced pro-inflammatory cytokines, including interleukin-6, interleukin-1β, and tumor necrosis factor α. The anti-inflammatory potential of EMSF6 was mediated through the downregulation of inducible nitric oxide synthase and cyclooxygenase-2 expression. Thus, fucoidans from E. maxima stipe are promising candidates for functional food products.


coronavirus disease 2019
diethylaminoethyl cellulose
fourier transform infrared spectroscopy
inducible nitric oxide synthase
nuclear magnetic resonance
prostaglandin E2
tumor necrosis factor α


Seaweeds continue to attract considerable attention in industrial and scientific fields because they serve as abundant sources of natural products, such as proteins, polysaccharides, lipids, and polyphenols, which are associated with antioxidant, anti-inflammatory, and anti-cancer activities. Several bioactive compounds derived from seaweed have been identified (Mayer et al. 2019, Lee et al. 2020) and are potentially used for industrial and commercial purposes (Camacho et al. 2019). Therefore, the aquaculture of seaweeds is considered the most important sustainable bioresources. Some edible seaweeds including Pyropia, Undaria, and Saccharina species successfully cultivated (Hwang and Park 2020) and artificial seed production and cultivation techniques were also developed in Korea (Carrano et al. 2020, Ko et al. 2020).
Seaweed is a promising source of secondary metabolites and it has several advantages, such as high availability and low processing costs for industrial purposes compared with the land plant. Recently, brown algae have received great attention because of their bioactive compounds, especially the polysaccharide fucoidan, which contains an abundance of sulfate groups that exhibit various biological activities. Sulfated polysaccharides are major components of brown seaweed and exhibit various bioactivities, including anti-coagulant, antioxidant, anti-inflammatory, anti-cancer, anti-microbial, anti-viral, and hepatoprotective activities (Sanjeewa et al. 2018).
The functional food industry has become the most profitable and rapidly growing industry worldwide because of the increased concern for human health owing to coronavirus disease 2019 (COVID-19). According to statistical reports, the global functional food market has been steadily growing, with the highest market share recorded in the United States (34.1%), China (15.1%), and the European Union (12.3%); the revenue of functional food products in the United States was 48,892 million USD in 2019 (KHSA 2021). Functional food products against immune and underlying diseases, including obesity, type 2 diabetes, and hypertension, have gained increased popularity in modern society. An early publication on food science and COVID-19 reported that specific dietary components and food supplements are important for the prevention of COVID-19 (Lange 2021). Therefore, the intake of functional foods is a good choice for managing human health during the COVID-19 pandemic. Recently, several synthetic COVID-19 treatments have been developed. However, these treatments evoke undesirable and severe side effects (e.g., fever, tiredness, headache, muscle ache, chills, diarrhea, pain, and redness). Management of the immune system is important to avoid undesirable side effects. Therefore, the sales of immune-related functional food products exponentially increased with the COVID-19 pandemic (Altun et al. 2021, Hamid et al. 2021).
The brown seaweed Ecklonia maxima belongs to the genus Ecklonia and is typically grown in Cape Town, South Africa (Rothman et al. 2006). Most studies have focused on ecological aspects (Crouch and Van Staden 1991, Anderson et al. 1997, Bolton et al. 2012) and efforts have been made to utilize the functional materials from E. maxima as biostimulants in agriculture (Stirk et al. 2014, Rengasamy et al. 2015). Seaweed hydrolysate and its functional ingredients are frequently used in the food and functional food industry. Earlier studies have revealed that fucoidan from E. maxima shows antioxidant and antidiabetic activities (Rengasamy et al. 2013, Daub et al. 2020). Wang et al. (2020) also reported various cosmeceutical activities, including antioxidant, anti-melanogenesis, and UV-protective activities, in vitro and in vivo (Wang et al. 2020). Enzyme-assisted hydrolysate from the stipe of E. maxima has antioxidant and anti-inflammatory potential (Lee et al. 2021). In this study, we purified fucoidan fractions from enzyme-assisted hydrolysate from E. maxima stipe and assessed its inhibitory activity on inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression using western blotting. We hypothesized that fucoidan from E. maxima possesses anti-inflammatory properties. The results of this study may contribute to the utilization of E. maxima in the functional food industry.



Lipopolysaccharide and standard fucoidan were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), penicillin/streptomycin (P/S), and trypsin-EDTA solution were purchased from Welgene (Daegu, Korea). Pro-inflammatory cytokines, such as interleukin-6 (IL-6), tumor necrosis factor α (TNF-α), and prostaglandin E2 (PGE2) were analyzed using a commercial colorimetric enzyme-linked immunosorbent assay kit from R&D Systems (Minneapolis, MN, USA). Food-grade Viscozyme obtained from Novozyme (Copenhagen, Denmark).

Sample preparation and fucoidan purification via ion-exchange chromatography

E. maxima stipe was kindly provided by the University of Cape Town, South Africa, and hydrolyzed using Viscozyme, as described by Lee et al. (2021). Briefly, 10 g of homogenized E. maxima stipe suspended in 1 L of distilled water and hydrolyzed with Viscozyme. After 24 h, the mixture was centrifuged (4°C, 12,000 rpm) and filtered. The filtrate was combined with double the volume of 95% EtOH and incubated at 4°C for 24 h. Twenty-four hours later, the precipitate was collected by centrifugation. The collected precipitate dried and homogenized using a grinder. The collected precipitate was named as crude polysaccharide. Then, the crude polysaccharide of Viscozyme-assisted hydrolysate from E. maxima stipe (EMSV) was purified using methods previously established by Jayawardena et al. (2020). For fucoidan purification, the crude polysaccharide was dissolved and filtered with a syringe filter (pore size, 0.45 μm) and introduced to diethylaminoethyl cellulose (DEAE-C), which was positively charged in sodium acetate buffer (50 mM). Fucoidan fractions were separated by gradient sodium chloride elution (50–2,000 mM). The separated fucoidan fractions were dialyzed to remove the remaining sodium and freeze-dried for in vitro experiments.

Proximate composition analysis

Association of Official Analytical Chemists methods were implemented to analyze the total carbohydrate, protein, polyphenol, and sulfate concentrations in fucoidans from E. maxima stipe (Horwitz et al. 1970).

Analysis of monosaccharide composition

The monosaccharide compositions were analyzed using high-performance anion-exchange chromatography with pulsed amperometric detection (Bio-LC System; Dionex, Sunnyvale, CA, USA) equipped with a CarboPac PA1 column (4.5 × 50 mm) and ED50 electrochemical detector (Dionex). All analytical fucoidan fractions were acid-hydrolyzed with 4 M trifluoroacetic acid. The acid hydrolysates were subjected to a separation column and the monosaccharide amount was calculated without considering the unhydrolyzed components.

Structural characterization by fourier transform infrared spectroscopy and 1H nuclear magnetic resonance analysis

Fourier transform infrared (FTIR) spectra of the fucoidan fraction and standard fucoidan were analyzed using an Alphall FTIR spectrometer (Bruker, Germany). The FTIR spectrum was analyzed in transmittance mode and wave number set in the range of 500–2,000 cm−1 wavenumber with optimal analytic conditions (transmittance mode, resolution: 4 cm−1, 24 scans). For proton nuclear magnetic resonance (NMR) analysis, purified fucoidan was prepared by pre-saturation with deuterium oxide. Briefly, 1 mg of purified fucoidan was dissolved in deuterium oxide and transferred to an NMR tube. The prepared NMR tube was then subjected to a Bruker Avance 800 MHz NMR spectrometer (Bruker, Rheinstetten, Germany) with a magnetic field of 18.8 T. The 1H NMR spectrum was obtained using 64 scans, and the chemical shifts are given in ppm.

Cell culture

Murine macrophage cells (RAW 264.7) were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). RAW 264.7 cells were grown in DMEM containing 10% FBS and 1% P/S and periodically sub-cultured every two-day interval.

Evaluation of the nitric oxide inhibitory potential of fucoidan from Ecklonia maxima stipe

Nitric oxide (NO) inhibitory effects were assessed using the Griess assay, according to Sanjeewa et al. (2019). Briefly, RAW 264.7 cells were plated in 96-well plates at a concentration of 1 × 105 cells well−1 for 24 h. Then, the cells were treated with the samples 1 h before lipopolysaccharide (LPS) stimulation and incubated for 24 h in an incubator. After 24 h, 100 μL of cell culture medium was collected, mixed with Griess solution (2 mg mL−1), and incubated in the dark for 37°C, 10 min. NO production was measured at 500 nm using a Synergy HT Multi-Detection microplate reader (Bio-Tek, Winooski, VT, USA).

Measurement of pro-inflammatory cytokines

RAW 264.7 cells were plated as explained in 2.7, treated with samples 1 h before LPS stimulation, and incubated for an additional 24 h. After 24 h, the cell culture medium was retrieved and pro-inflammatory cytokines (IL-6, TNF-α, and IL-1β) were analyzed using a commercial colorimetric kit following the manufacturer’s protocols.

Western blot analysis

Western blotting was performed according to the method described by Fernando et al. (Fernando et al. 2018). The amounts of activated iNOS and COX-2 proteins were evaluated, and images of western blots were taken using a FUSION SOLO Vilber Lourmat system (Paris, France). The intensities of the developed bands were quantified using ImageJ (version 1.4; National Institutes of Health, Bethesda, MD, USA).

Statistical analysis

All measurements were analyzed in independent triplicate and presented as the mean ± standard deviation. Statistic evaluation was conducted using the statistical package for the GraphPad Prism (version 9.4.1; GraphPad Software Inc., San Diego, CA, USA). p-values (*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 compared with the LPS-treated group; #p < 0.05, ##p < 0.01, ###p < 0.001, and ####p < 0.0001 compared with the LPS-untreated group) of <0.05 were considered significant.


Enzyme-assisted hydrolysis, fucoidan purification, and chemical composition analysis

Enzyme-mediated hydrolyzation was performed on E. maxima stipe, and Viscozyme-assisted hydrolysate was selected as a potential candidate for in vitro studies. In total, six fucoidan fractions were obtained via DEAE-C and anion-exchange chromatography, and the DEAE-C chromatogram is presented in Fig. 1. The chemical compositions of the fucoidan fractions are illustrated in Table 1. Accordingly, fucoidan fraction 6 of Viscozyme-assisted hydrolysate from E. maxima stipe (EMSF6) possessed the highest total carbohydrate (51.77 ± 0.47%) and sulfate contents (35.88 ± 0.36%), respectively. However, a low polyphenol content (0.15 ± 0.12%) was detected in EMSF6. The chemical composition (total polysaccharide, sulfate, and polyphenol) are summarized in Table 1.

Monosaccharide compositions of EMSFs

The monosaccharide contents were calculated by comparison with standard monosaccharide mixtures (fucose, rhamnose, arabinose, galactose, glucose, mannose, and fructose), and are tabulated in Table 2. The fucose and galactose contents exhibited an increasing trend during DEAE-C purification. However, other monosaccharides did not exhibit any particular trends.

Determination of structural characters via FTIR and 1H NMR analysis

FTIR spectroscopy was performed on the EMSFs, and the IR spectrum was recorded in the range of 500–2,000 cm−1. The FTIR peak (840–845 cm−1) is attributed to a sulfate group substitution at the C-4 position, and the intense FTIR peak (1,025–1,035 cm−1) is attributed to the stretching of the C-O-C bond. The broad FTIR peak at 1,220–1,270 indicates sulfate groups (S=O). (Fig. 2A). The 1H NMR spectrum of the deuterium oxide exchange reaction of EMSF6 is shown in Fig. 2B. In the 1H NMR spectrum, a deuterium EtOH peak was observed at 2.0–2.2 ppm. The α-l-Fucf-(1→4) residues and methyl protons were detected at 0.9 and 1.3 ppm, respectively. The intense peak at 3.5–4.0 ppm is attributable to a sugar residue.

Potential anti-inflammatory effect of EMSFs in reducing LPS-induced inflammatory response in RAW 264.7 cells

The effects of EMSFs on LPS-induced cell viability and NO production are shown in Fig. 3. Cell viability significantly decreased, and NO production increased in LPS-induced RAW 264.7 cells compared with LPS-untreated groups. Treatment with EMSFs resulted in a recovery of cell viability and NO levels were significantly reduced by EMSF pre-treatment. Among the EMSFs, the EMSF6-treated group showed high cell viability and low NO production levels. The IC50 value of EMSF6 on NO production was recorded as 75.81 ± 7.55 μg mL−1. Therefore, EMSF6 was selected as a potential candidate for further in vitro studies.

Effect of EMSF6 on inflammatory mediators in LPS-induced RAW 264.7 cells

Next, we investigated the inhibitory effects of EMSF6 on LPS-induced pro-inflammatory cytokine (IL-6, TNF-α, and PGE2) production. LPS treatment significantly increased the production of these pro-inflammatory cytokines (Fig. 4). However, EMSF6 significantly decreased the levels of those cytokines such as IL-6 and PGE2.

Potential of EMSF6 to inhibit LPS-induced iNOS, COX-2, and p-p38 protein expression

To elucidate the mechanisms underlying the anti-inflammatory effect of EMSF6, we analyzed the protein expression levels of iNOS and COX-2 using western blotting. Fig. 5A and B shows the protein expression bands of iNOS and COX-2 and their relative protein expression. LPS stimulated increases in iNOS, COX-2, and p-p38 expression. However, the levels of inflammatory iNOS and COX-2 proteins and the phosphorylation of p38 gradually decreased with EMSF6 treatment. These results indicate that EMSF6 effectively regulates major inflammatory mediators and proteins after LPS induction.


Fucoidan, a sulfated polysaccharide, is the most important functional ingredient found in brown seaweed and has a high sulfate and fucose content. Therefore, the abundance of fucoidan was indirectly calculated by measuring the fucose and sulfate content. Previous studies have reported that the bioactivities, mainly antioxidant and anti-inflammatory activities, of fucoidans from different brown seaweeds are determined by the sulfate content (Jayawardena et al. 2019, Wang et al. 2019). Several studies have investigated the practical application of brown seaweed fucoidan in food or functional food products and for medical or pharmaceutical purposes (Citkowska et al. 2019, Fitton et al. 2019, Chen et al. 2021). Therefore, in the current study, we investigated the potential anti-inflammatory activity of fucoidans isolated from E. maxima stipe. In total, six fucoidans were obtained from E. maxima and their chemical / monosaccharide composition and anti-inflammatory potential were evaluated. Physical characteristics were determined by FTIR and 1H NMR spectroscopy. According to the chemical composition analysis, EMSFs consisted of a high polysaccharide and sulfate content and traceable amounts of protein and polyphenol. The monosaccharide composition results showed high fucose and galactose contents in EMSF6. These results demonstrate that fucose and galactose were highly concentrated during the purification step, which may be attributed to their potential anti-inflammatory activity. FTIR spectroscopy revealed that the purified EMSF6 showed FTIR spectrum patterns similar to those of commercial fucoidan. These results are solidified by previously published studies (Fernando et al. 2020, Wang et al. 2020). Additionally, 1H NMR results supported that EMSF6 has specific structural similarities with commercial fucoidans. Based on our structural determination and chemical / monosaccharide characterization, we estimated that EMSF6 is a fucoidan (Sanjeewa et al. 2019).
Pro-inflammatory cytokines are responsible for inflammation during tissue damage. Under these conditions, the production of pro-inflammatory cytokines and NO quickly increases, which increases the activation of immune-related cells to remove infected cells and sources of infection. In in vitro anti-inflammatory studies, EMSF6 showed the strongest NO inhibitory activity, and NO production was inhibited up to 1.62 ± 0.69-fold. Our previous study revealed that EMSV exhibits 4––4.5-fold NO inhibition compared with the LPS-untreated group (Lee et al. 2021). However, pro-inflammatory cytokines were also highly suppressed by EMSF6 compared with EMSV. Our findings demonstrated that the inhibitory activities on NO and pro-inflammatory cytokine production were increased by DEAE-C, and anion-exchange chromatography showed that purified fucoidan had higher NO inhibitory activity than EMSV. Based on our findings, we investigated the anti-inflammatory mechanism of EMSF6. In the pro-inflammatory cytokine analysis, IL-6 and PGE2 production were significantly decreased. Earlier studies have reported that COX-2 and iNOS support the decrease in the levels of these pro-inflammatory cytokines by regulation of immune-related gene expression (Liu et al. 2021, Yang et al. 2022). The current study indicated a significant downstream effect of iNOS and COX-2 in EMSF6 and LPS-treated RAW 264.7 cells. Collectively, our findings demonstrated that EMSF6 exhibited anti-inflammatory activity by regulating pro-inflammatory cytokines and protein expression of iNOS and COX-2 in LPS-induced RAW 264.7 cells.
Fucoidan from E. maxima stipe possesses potent anti-inflammatory activity by downregulating pro-inflammatory cytokines and suppressing protein expression of iNOS and COX-2 in LPS-induced RAW 264.7 cells. The results suggest that fucoidan from E. maxima stipe can be used as a functional ingredient in the food and functional food industry.


This research was a part of the project entitled “Discovering a process technology to develop alginic acid in mass scale for domestic uses,” funded by the Ministry of Oceans and Fisheries, Korea (20220560). Further, the Korea Research Program 2022M00500 extended its support via the National Marine Biodiversity Institute of Korea.


The authors declare that they have no potential conflicts of interest.

Fig. 1
Purification of fucoidans from Ecklonia maxima stem via diethylaminoethyl cellulose, anion-exchange chromatography. EMSF, fucoidan of Viscozyme-assisted hydrolysate from E. maxima.
Fig. 2
Determination of structural characteristics of EMSF6 and commercial fucoidan by fourier transform infrared spectroscopy (FTIR) (A) and 1H nuclear magnetic resonance (1H NMR) spectrum (B). EMSF, fucoidan of Viscozyme-assisted hydrolysate from Ecklonia maxima.
Fig. 3
Anti-inflammatory effects of EMSFs against lipopolysaccharide (LPS)-induced inflammatory response in RAW 264.7 macrophages. Cell viability (A) and nitric oxide (NO) production inhibition (B) by treatment of EMSFs. EMSF, fucoidan of Viscozyme-assisted hydrolysate from Ecklonia maxima; EMSV, Viscozyme-assisted hydrolysate from E. maxima stipe; CPS, crude polysaccharide. Experiments were done in triplicate and the results are expressed as mean ± standard deviation. Significant difference identified at **p < 0.01, ***p < 0.001 as compared to LPS-treated group; ####p < 0.0001 as compared to LPS-untreated group.
Fig. 4
EMSF6 inhibited the production of interleukin 6 (IL-6) (A), tumor necrosis factor α (TNF-α) (B), and prostaglandin E2 (PGE2) proinflammatory cytokines (C). EMSF, fucoidan of Viscozyme-assisted hydrolysate from Ecklonia maxima; LPS, lipopolysaccharide. Experiments were done in triplicate and the results are expressed as mean ± standard deviation. Significant difference identified at *p < 0.05, **p < 0.01, ***p < 0.001 as compared to LPS-treated group; #p < 0.05, ###p < 0.001 as compared to LPS-untreated group.
Fig. 5
Effects of the EMSF6 on mediating lipopolysaccharide (LPS)- induced induc ible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and p-p38 protein expression in RAW 264.7 cells. Western blot bands (A) and quantification graph (B) for iNOS, COX-2, and p-p38 in LPS-induced RAW 264.7 cells. EMSF, fucoidan of Viscozymeassisted hydrolysate from Ecklonia maxima. Experiments were done in triplicate and the results are expressed as mean ± standard deviation. Significant difference identified at **p < 0.01, ***p < 0.001, and ****p < 0.0001 as compared to LPS-treated group; ##p < 0.01, ####p < 0.0001 as compared to LPS-untreated group.
Table 1
Chemical composition of fucoidans of Viscozyme-assisted hydrolysate from Ecklonia maxima (EMSFs)
DEAE-C fractions Chemical composition (%)

Polysaccharide Sulfate Polyphenol
EMSF1 85.90 ± 0.16 14.30 ± 0.36 0.83 ± 0.00
EMSF2 91.99 ± 0.94 9.28 ± 0.12 0.45 ± 0.06
EMSF3 63.91 ± 0.24 4.19 ± 0.06 0.58 ± 0.12
EMSF4 37.14 ± 0.16 0.21 ± 0.12 0.70 ± 0.06
EMSF5 53.21 ± 1.72 16.76 ± 0.18 0.19 ± 0.06
EMSF6 51.77 ± 0.47 35.88 ± 0.36 0.15 ± 0.12

DEAE-C, diethylaminoethyl cellulose.

Table 2
Monosaccharide composition of fucoidans of Viscozyme-assisted hydrolysate from Ecklonia maxima (EMSFs)
DEAE-C fractions Monosugar composition (%)

Fucose Rhamnose Arabinose Galactose Glucose
EMSF1 69.96 1.18 0.44 11.31 3.44
EMSF2 36.91 1.69 0.13 25.48 5.02
EMSF3 34.00 2.20 0.84 8.71 7.49
EMSF4 36.37 2.04 0.08 9.17 1.97
EMSF5 60.02 0.96 0.08 35.03 -
EMSF6 68.33 1.16 0.05 24.52 -

DEAE-C, diethylaminoethyl cellulose.


Altun, HK., Ermumcu, MSK. & Kurklu, NS. 2021. Evaluation of dietary supplement, functional food and herbal medicine use by dietitians during the COVID-19 pandemic. Public Health Nutr. 24:861–869.
crossref pmid pmc
Anderson, RJ., Carrick, P., Levitt, GJ. & Share, A. 1997. Holdfasts of adult kelp Ecklonia maxima provide refuges from grazing for recruitment of juvenile kelps. Mar Ecol Prog Ser. 159:265–273.
Bolton, JJ., Anderson, RJ., Smit, AJ. & Rothman, MD. 2012. South African kelp moving eastwards: the discovery of Ecklonia maxima (Osbeck) Papenfuss at De Hoop Nature Reserve on the south coast of South Africa. Afr J Mar Sci. 34:147–151.
Camacho, F., Macedo, A. & Malcata, F. 2019. Potential industrial applications and commercialization of microalgae in the functional food and feed industries: a short review. Mar Drugs. 17:312 pp.
crossref pmid pmc
Carrano, MW., Yarimizu, K., Gonzales, JL., Cruz-López, R., Edwards, MS., Tymon, TM., Küpper, FC. & Carrano, CJ. 2020. The influence of marine algae on iodine speciation in the coastal ocean. Algae. 35:167–176.
crossref pdf
Chen, P-H., Chiang, P-C., Lo, W-C., Su, C-W., Wu, C-Y., Chan, C-H., Wu, Y-C., Cheng, H-C., Deng, W-P., Lin, H-K. & Peng, B-Y. 2021. A novel fucoidan complex-based functional beverage attenuates oral cancer through inducing apoptosis, G2/M cell cycle arrest and retarding cell migration/invasion. J Funct Foods. 85:104665 pp.
Citkowska, A., Szekalska, M. & Winnicka, K. 2019. Possibilities of fucoidan utilization in the development of pharmaceutical dosage forms. Mar Drugs. 17:458 pp.
crossref pmid pmc
Crouch, IJ. & Van Staden, J. 1991. Evidence for rooting factors in a seaweed concentrate prepared from Ecklonia maxima . J Plant Physiol. 137:319–322.
Daub, CD., Mabate, B., Malgas, S. & Pletschke, BI. 2020. Fucoidan from Ecklonia maxima is a powerful inhibitor of the diabetes-related enzyme, α-glucosidase. Int J Biol Macromol. 151:412–420.
crossref pmid
Fernando, IPS., Sanjeewa, KKA., Lee, HG., Kim, H-S., Vaas, APJP., De Silva, HIC., Nanayakkara, CM., Abeytunga, DTU., Lee, D-S., Lee, J-S. & Jeon, Y-J. 2020. Fucoidan purified from Sargassum polycystum induces apoptosis through mitochondria-mediated pathway in HL-60 and MCF-7 cells. Mar Drugs. 18:196 pp.
crossref pmid pmc
Fernando, IPS., Sanjeewa, KKA., Samarakoon, KW., Lee, WW., Kim, H-S., Ranasinghe, P., Gunasekara, UKDSS. & Jeon, Y-J. 2018. Antioxidant and anti-inflammatory functionality of ten Sri Lankan seaweed extracts obtained by carbohydrase assisted extraction. Food Sci Biotechnol. 27:1761–1769.
crossref pmid pmc pdf
Fitton, JH., Stringer, DN., Park, AY. & Karpiniec, SS. 2019. Therapies from fucoidan: new developments. Mar Drugs. 17:571 pp.
crossref pmid pmc
Hamid, H., Thakur, A. & Thakur, NS. 2021. Role of functional food components in COVID-19 pandemic: a review. Ann Phytomed Int J. 10:S240–S250.
Horwitz, W., Chichilo, P. & Reynolds, H. 1970 Official methods of analysis of the Association of Official Analytical Chemists. Association of Official Analytical Chemists, Washinton, DC, 1015 pp.

Hwang, EK. & Park, CS. 2020. Seaweed cultivation and utilization of Korea. Algae. 35:107–121.
crossref pdf
Jayawardena, TU., Fernando, IPS., Lee, WW., Sanjeewa, KKA., Kim, H-S., Lee, D-S. & Jeon, Y-J. 2019. Isolation and purification of fucoidan fraction in Turbinaria ornata from the Maldives: inflammation inhibitory potential under LPS stimulated conditions in in-vitro and in-vivo models. Int J Biol Macromol. 131:614–623.
crossref pmid
Jayawardena, TU., Sanjeewa, KKA., Nagahawatta, DP., Lee, H-G., Lu, Y-A., Vaas, APJP., Abeytunga, DTU., Nanayakkara, CM., Lee, D-S. & Jeon, Y-J. 2020. Anti-Inflammatory effects of sulfated polysaccharide from Sargassum swartzii in macrophages via blocking TLR/NF-κb signal transduction. Mar Drugs. 18:601 pp.
crossref pmid pmc
KHSA (Korea Health Supplements Association) 2021. Sales revenue of world functional food products in 2019, Available from: https://www.khsa.or.kr/user/info/InfoExternalHealth.do . Accessed Aug 4, 2022

Ko, SJ., Kim, YK., Hong, SW., Kang, MS., Park, CS., Hwang, EK. & Lee, YD. 2020. Artificial seed production and cultivation of Sargassum macrocarpum (Fucales, Phaeophyta). Algae. 35:123–131.
crossref pdf
Lange, KW. 2021. Food science and COVID-19. Food Sci Hum Wellness. 10:1–5.
crossref pmc
Lee, H-G., Je, J-G., Hwang, J., Jayawardena, TU., Nagahawatta, D., Lu, YA., Kim, H-S., Kang, M-C., Lee, D-S. & Jeon, Y-J. 2021. Comparision of antioxidant and anti-inflammatory activities of enzyme assisted hydrolysate from Ecklonia maxima blades and stipe. Fish Aquat Sci. 24:197–206.
crossref pdf
Lee, SM., Kim, N-H., Ji, YK., Kim, YN., Jeon, Y-J., Heo, JD., Jeong, EJ. & Rho, J-R. 2020. Sulfoquinovosylmonoacylglycerols regulating intestinal inflammation in co-culture system from the brown alga Turbinaria ornata . Algae. 35:201–212.
crossref pdf
Liu, X., Su, J., Wang, G., Zheng, L., Wang, G., Sun, Y., Bao, Y., Wang, S. & Huang, Y. 2021. Discovery of phenolic glycoside from Hyssopus cuspidatus attenuates LPS-induced inflammatory responses by inhibition of iNOS and COX-2 expression through suppression of NF-κB activation. Int J Mol Sci. 22:12128 pp.
crossref pmid pmc
Mayer, AMS., Guerrero, AJ., Rodríguez, AD., Taglialatela-Scafati, O., Nakamura, F. & Fusetani, N. 2019. Marine pharmacology in 2014–2015 marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, antiviral, and anthelmintic activities: affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mar Drugs. 18:5 pp.
crossref pmid pmc
Rengasamy, KRR., Aderogba, MA., Amoo, SO., Stirk, WA. & Van Staden, J. 2013. Potential antiradical and alpha-glucosidase inhibitors from Ecklonia maxima (Osbeck) Papenfuss. Food Chem. 141:1412–1415.
crossref pmid
Rengasamy, KR., Kulkarni, MG., Stirk, WA. & Van Staden, J. 2015. Eckol: a new plant growth stimulant from the brown seaweed Ecklonia maxima . J Appl Phycol. 27:581–587.
crossref pdf
Rothman, MD., Anderson, RJ. & Smit, AJ. 2006. The effects of harvesting of the South African kelp (Ecklonia maxima) on kelp population structure, growth rate and recruitment. J Appl Phycol. 18:335–341.
crossref pdf
Sanjeewa, KKA., Jayawardena, TU., Kim, H-S., Kim, S-Y., Fernando, IPS., Wang, L., Abetunga, DTU., Kim, W-S., Lee, D-S. & Jeon, Y-J. 2019. Fucoidan isolated from Padina commersonii inhibit LPS-induced inflammation in macrophages blocking TLR/NF-κB signal pathway. Carbohydr Polym. 224:115195 pp.
crossref pmid
Sanjeewa, KKA., Kang, N., Ahn, G., Jee, Y., Kim, Y-T. & Jeon, Y-J. 2018. Bioactive potentials of sulfated polysaccharides isolated from brown seaweed Sargassum spp in related to human health applications: a review. Food Hydrocoll. 81:200–208.
Stirk, WA., Tarkowská, D., Turečová, V., Strnad, M. & Van Staden, J. 2014. Abscisic acid, gibberellins and brassinosteroids in Kelpak, a commercial seaweed extract made from Ecklonia maxima . J Appl Phycol. 26:561–567.
crossref pdf
Wang, L., Jayawardena, TU., Yang, H-W., Lee, H-G. & Jeon, Y-J. 2020. The potential of sulfated polysaccharides isolated from the brown seaweed Ecklonia maxima in cosmetics: antioxidant, anti-melanogenesis, and photoprotective activities. Antioxidants. 9:724 pp.
crossref pmid pmc
Wang, L., Oh, JY., Hwang, J., Ko, JY., Jeon, Y-J. & Ryu, B. 2019. In vitro and in vivo antioxidant activities of polysaccharides isolated from celluclast-assisted extract of an edible brown seaweed, Sargassum fulvellum . Antioxidants. 8:493 pp.
crossref pmid pmc
Yang, L., Cao, L., Li, C., Li, X., Wang, J., Chen, H. & He, J. 2022. Hostaflavone A from Hosta plantaginea (lam.) Asch. blocked NF-κB/iNOS/COX-2/MAPKs/Akt signaling pa- thways in LPS-induced RAW 264.7 macrophages. J Ethnopharmacol. 282:114605 pp.
crossref pmid
PDF Links  PDF Links
PubReader  PubReader
ePub Link  ePub Link
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Web of Science
Related article
Editorial Office
[14348] A-1716, Gwangmyeong Trade Center, 72 Iljik-ro Gwangmyeong-si. Gyeonggi-do, Korea
Tel: +82-2-899-5980  Fax: +82-2-899-5922    E-mail: editalgae@gmail.com
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Society of Phycology.                 Developed in M2PI